CROs/Service Providers

Quintiles launches Solution Design Studio

Monday, June 27, 2016

Quintiles, the world’s largest provider of product development and integrated healthcare services, has opened its global Solution Design Studio where expert teams will collaborate to create technology solutions that tackle some of healthcare’s biggest challenges.

[Read More]

BlueTheory rebrands to BTC Network, launches new business model

Monday, June 27, 2016

BlueTheory Clinical Trials, a clinical research network company headquartered in Boston, Massachusetts has been partnering with pharmaceutical and CROs to bring treatments and devices to the market since its inception. Based on increased demands from BlueTheory’s over 30 aligned pharmaceutical and CRO strategic partners, BlueTheory has enhanced its site business model and is announcing its rebrand to BTC Network.

[Read More]

Study: Support for ‘Bring Your Own Device’ approach in clinical trials

Friday, June 17, 2016

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced research showing many pharmaceutical and CROs support the use of a ‘Bring Your Own Device’ (BYOD) approach in clinical studies, enabling patients to use their own mobile devices to collect patient-reported outcomes (PRO) data. The research highlights how commonly-cited concerns around the use of patients’ own devices are not as much of a deterrent to adoption as is often thought.

[Read More]

Bioclinica to launch patient engagement divisions

Friday, June 17, 2016

Bioclinica, a specialty clinical trials technology and services provider, has announced two new divisions, creating an integrated offering focused on patient engagement. With the announcement comes the combination of Bioclinica’s extensive global clinical research site network and patient recruitment-retention engine under the Global Clinical Research business segment.

[Read More]

Pfizer inks service agreements with Icon, Parexel

Friday, June 17, 2016

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer. Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed.

[Read More]

Biologics Consulting launches Clinical Trials Planning and Oversight Group

Wednesday, June 8, 2016

Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, has launched its Clinical Trials Planning and Oversight Group. The group will help small and medium-sized biopharmaceutical companies in the development and management of efficient and cost effective clinical trials. Biologics Consulting has a broad range of global clinical trial experience and clinical operations expertise that it will leverage to help clients design trials to meet the ethical, regulatory and scientific standards required to obtain successful product development outcomes.

[Read More]

Accelovance acquires THERAMetrics’ CRO services

Wednesday, June 8, 2016

Accelovance, a global CRO focusing in vaccines, oncology, and general medicine, has announced further expansion of European CRO services with the acquisition of THERAMetrics Holding‘s three CRO subsidiaries and phase I unit in Germany, Italy and Romania. In addition to the employees and facilities associated with these European subsidiaries, Accelovance will also assume management of THERAMetrics’ ongoing clinical program work in the U.S.

[Read More]

genae opens offices in San Francisco

Monday, June 6, 2016

genae, a global CRO and service provider for the medical industries, has expanded its North American activities with the opening of offices in San Francisco. genae Americas was incorporated in 2011 and has since then opened offices in New York City and Cleveland, Ohio.

[Read More]